Home NDC 50242-245 Phesgo
Product NDC 50242-245
11-digit product format 502420245
Labeler code 50242
Product ID 50242-245_9d068707-f189-4f0f-a74e-17bbe1f10476
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name pertuzumab, trastuzumab, and hyaluronidase-zzxf
Dosage form INJECTION, SOLUTION
Route SUBCUTANEOUS
Labeler Genentech, Inc.
Application BLA761170
Marketing category BLA
Marketing start 2020-06-29
Substance HYALURONIDASE (HUMAN RECOMBINANT); PERTUZUMAB; TRASTUZUMAB
Active strength 30000; 1200; 600 U/15mL; mg/15mL; mg/15mL
Pharmacologic classes Endoglycosidase [EPC], Glycoside Hydrolases [CS], HER2/Neu/cerbB2 Antagonists [MoA], HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC], HER2/neu Receptor Antagonist [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base Phesgo
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength PERTUZUMAB 30000 U/15mL TRASTUZUMAB 1200 mg/15mL HYALURONIDASE (HUMAN RECOMBINANT) 600 mg/15mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 3 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination P188ANX8CK Internal UNII lookup K16AIQ8CTM Internal UNII lookup 743QUY4VD8 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2382604 Internal RxNorm lookup 2382609 Internal RxNorm lookup 2383305 Internal RxNorm lookup 2383307 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 50242-245-01 Phesgo 15 mL in 1 VIAL, SINGLE-DOSE INJECTION, SOLUTION 15 17 50242-245-01 Phesgo 1 in 1 CARTON INJECTION, SOLUTION 1 17 50242-245-86 Phesgo 1 in 1 CARTON INJECTION, SOLUTION 1 17 50242-245-86 Phesgo 15 mL in 1 VIAL, SINGLE-DOSE INJECTION, SOLUTION 15 17
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50242-245 PHESGO (PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF) INJECTION, SOLUTION [GENENTECH, INC.] 10 Current NDC, Legacy NDC, 4 package rows 20241206_27dd5e6b-72cd-458d-a015-cf4dab5800da.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Phesgo PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF Genentech, Inc. 27dd5e6b-72cd-458d-a015-cf4dab5800da 2026-05-21 Boxed warning, Warnings, Adverse reactions Exact identifier application number: BLA761170 ndc (product): 50242-245
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761170 Phesgo pertuzumab, trastuzumab, and hyaluronidase-zzxf 351(a) Rx 2026-07-01
DailyMed RxNorm Mappings# RxCUI, RxNorm string, TTY table RxCUI RxNorm string TTY DailyMed SPL version 2382604 pertuzumab-trastuzumab-hyaluronidase-zzxf 1,200 MG / 600 MG / 30,000 UNT in 15 mL Injection PSN 27dd5e6b-72cd-458d-a015-cf4dab5800da 17 2383305 pertuzumab-trastuzumab-hyaluronidase-zzxf 600 MG / 600 MG / 20,000 UNT in 10 ML Injection PSN 27dd5e6b-72cd-458d-a015-cf4dab5800da 17 2382609 PHESGO 1,200 MG / 600 MG / 30,000 UNT in 15 ML Injection PSN 27dd5e6b-72cd-458d-a015-cf4dab5800da 17 2383307 Phesgo 600 MG / 600 MG / 20,000 UNT in 10 mL Injection PSN 27dd5e6b-72cd-458d-a015-cf4dab5800da 17 2383307 10 ML hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 60 MG/ML / trastuzumab-zzxf 60 MG/ML Injection [Phesgo] SBD 27dd5e6b-72cd-458d-a015-cf4dab5800da 17 2382609 15 ML hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 80 MG/ML / trastuzumab-zzxf 40 MG/ML Injection [Phesgo] SBD 27dd5e6b-72cd-458d-a015-cf4dab5800da 17 2383305 10 ML hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 60 MG/ML / trastuzumab-zzxf 60 MG/ML Injection SCD 27dd5e6b-72cd-458d-a015-cf4dab5800da 17 2382604 15 ML hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 80 MG/ML / trastuzumab-zzxf 40 MG/ML Injection SCD 27dd5e6b-72cd-458d-a015-cf4dab5800da 17 2382604 pertuzumab-trastuzumab-hyaluronidase-zzxf 1,200 MG / 600 MG / 30,000 UNT per 15 ML Injection SY 27dd5e6b-72cd-458d-a015-cf4dab5800da 17 2383305 pertuzumab-trastuzumab-hyaluronidase-zzxf 600 MG / 600 MG / 20,000 UNT per 10 ML Injection SY 27dd5e6b-72cd-458d-a015-cf4dab5800da 17 2382609 Phesgo 1,200 MG / 600 MG / 30,000 UNT per 15 ML Injection SY 27dd5e6b-72cd-458d-a015-cf4dab5800da 17 2383307 Phesgo 600 MG / 600 MG / 20,000 UNT per 10 ML Injection SY 27dd5e6b-72cd-458d-a015-cf4dab5800da 17
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 50242-245-01 50242024501 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-245-01) / 15 mL in 1 VIAL, SINGLE-DOSE 2020-06-29 0000-00-00 No No Current 50242-245-86 50242024586 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-245-86) / 15 mL in 1 VIAL, SINGLE-DOSE 2021-05-03 0000-00-00 Yes No Current